Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Movicol for Chronic Constipation in Children
NCT00403897Phase 3Completed
- Sponsor
- Norgine
- Start
- Aug 2001
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of polyethylene glycol in chronic constipation, sponsored by Norgine. Primary endpoint: Average number of spontaneous complete defaecations per week at 12 weeks. Started Aug 2001; status: completed.
02
Drugs
polyethylene glycol
03
Conditions
chronic constipation
Beyond the preview
Go deeper on NCT00403897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403897.